2NG-23455-59866

3 vaccinations 12 coded responses 30 check-ins 12 free-text entries 9 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 917 / CA
Registered: 2020-12-21

Relationship: Self
Race: Asian
Ethnicity: Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-21
Registered in v-safe
2020-12-21
Dose 1 — Pfizer-BioNTech
2020-12-22
Survey response — days 1–6 daily, dose 1
MedDRA: Rash, Rash erythematous, Rash pruritic — Feeling: Fair · Site: Pain · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Red itchy rash around neck & arms

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-22
Report sent to call center — days 1–6 daily, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2020-12-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Swelling · None

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Swelling · None

Adult check-in
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Redness, Swelling · None

Adult check-in
2020-12-30
Health check-in — day 7, dose 1
Feeling: Good · Site: Pain, Redness, Swelling · Headache · Be unable to work

Adult check-in
2020-12-30
Report sent to call center — day 7, dose 1
Be unable to work

1 call case(s)
2020-12-30
Call 1 — Left Voicemail
2021-01-05
Call 1 — Left Voicemail
2021-01-11
Dose 2 — Pfizer-BioNTech
2021-01-11
Call 2 — Left Voicemail
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work

Adult check-in
2021-01-13
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

1 call case(s)
2021-01-14
Call 1 — Left Voicemail
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Joint pains, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2021-01-16
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-17
Call 1 — Left Voicemail
2021-01-20
Survey response — day 7, dose 2
MedDRA: Rash — Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Free text: Intermittent rash

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-27
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-02-01
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-02-10
Survey response — day 28, dose 2
MedDRA: Urinary tract infection — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: UTI

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-10
Report sent to call center — day 28, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-17
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-02-22
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-12
Survey response — 3 months, dose 2
MedDRA: Fungal infection, Hypothyroidism, Nephrolithiasis, Urinary tract infection — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Urinary tract infection, yeast infection, kidney stones & Hypothyroidism

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-12
Report sent to call center — 3 months, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-10
Call successful
Participant prefers to complete VAERS report online
2021-09-27
Dose 3 — Pfizer-BioNTech
2021-09-28
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school

Adult check-in
2021-09-29
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-09-30
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-01
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-02
Survey response — days 1–6 daily, dose 3
MedDRA: Dysgeusia, Epistaxis — Feeling: Good

Free text: Metallic taste in mouth & bloody nose

MedDRA releases: 2024-11 · check-in free text available
2021-10-03
Survey response — days 1–6 daily, dose 3
MedDRA: Dysgeusia — Feeling: Good

Free text: Metallic taste in mouth

MedDRA releases: 2024-11 · check-in free text available
2021-10-06
Survey response — day 7, dose 3
MedDRA: Epistaxis, Upper-airway cough syndrome — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Free text: Intermittent epistaxis & Moderate post nasal drip

MedDRA releases: 2024-11 · check-in free text available
2021-10-11
Survey response — day 14, dose 3
MedDRA: Lymphadenopathy, Respiratory tract congestion, Upper-airway cough syndrome — Feeling: Fair

Free text: Swollen lymph node, congestion @ post nasal drip

MedDRA releases: 2024-11 · check-in free text available
2021-10-18
Survey response — day 21, dose 3
MedDRA: Sinusitis, Vasculitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Sinusitis & vascularitis

MedDRA releases: 2024-11 · check-in free text available
2021-10-18
Report sent to call center — day 21, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-10-19
Call 1 — Left Voicemail
2021-10-28
Survey response — day 28, dose 3
MedDRA: Pre-existing disease, Sleep disorder — Feeling: Fair · Be unable to work or attend school

Free text: Allergies & act of sleep

MedDRA releases: 2024-11 · check-in free text available
2021-11-02
Health check-in — day 35, dose 3
Feeling: Fair

Adult check-in
2021-12-27
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-03-31
Survey response — 6 months, dose 3
MedDRA: Endocarditis, Mitral valve replacement — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Endocarditis which led to mitral valve replacement cardiac surgery

MedDRA releases: 2024-11 · check-in free text available
2022-03-31
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-04-04
Call 1 — Left Voicemail
2022-04-04
Callback requested for
01:15PM ET
2022-04-04
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-09-29
Survey response — 12 months, dose 3
MedDRA: Endocarditis, Mitral valve incompetence, Mitral valve replacement, Surgery — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization

Free text: Symptoms: Endocarditis, mitral valve regurgitation & mitral replacement · Healthcare visit (other): Surgery

MedDRA releases: 2024-11 · check-in free text available
2022-09-29
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-09-30
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-21	Pfizer-BioNTech
2	2021-01-11	Pfizer-BioNTech
3	2021-09-27	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2020-12-22	Successful	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2020-12-30	Successful	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2021-01-13	Successful	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2021-01-16	Successful	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2021-02-10	Successful	Participant prefers to complete VAERS report online
2021-04-12	Successful 2021-06-10	Participant prefers to complete VAERS report online
2021-10-18	Successful	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-03-31	Successful 2022-04-04	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-09-29	Unsuccessful

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-22

Systemic reaction (other): Red itchy rash around neck & arms

Release 2 — day 7, dose 2

2021-01-20

Systemic reaction (other): Intermittent rash

Release 4 — day 28, dose 2

2021-02-10

Symptoms: UTI

Release 7 — 3 months, dose 2

2021-04-12

Symptoms: Urinary tract infection, yeast infection, kidney stones & Hypothyroidism

Release 9 — days 1–6 daily, dose 3

2021-10-02

Systemic reaction (other): Metallic taste in mouth & bloody nose

2021-10-03

Systemic reaction (other): Metallic taste in mouth

Release 10 — day 7, dose 3

2021-10-06

Systemic reaction (other): Intermittent epistaxis & Moderate post nasal drip

Release 10 — day 14, dose 3

2021-10-11

Symptoms: Swollen lymph node, congestion @ post nasal drip

Release 10 — day 21, dose 3

2021-10-18

Symptoms: Sinusitis & vascularitis

Release 10 — day 28, dose 3

2021-10-28

Symptoms: Allergies & act of sleep

Release 11 — 6 months, dose 3

2022-03-31

Symptoms: Endocarditis which led to mitral valve replacement cardiac surgery

Release 12 — 12 months, dose 3

2022-09-29

Symptoms: Endocarditis, mitral valve regurgitation & mitral replacement

Healthcare visit (other): Surgery

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Surgery	·	·	✓
SD	Endocarditis	·	·	✓
SD	Fungal infection	✓	✓	✓
SD	Hypothyroidism	✓	✓	✓
SD	Lymphadenopathy	·	·	✓
SD	Mitral valve incompetence	·	·	✓
SD	Mitral valve replacement	·	·	✓
SD	Nephrolithiasis	✓	✓	✓
SD	Pre-existing disease	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Sinusitis	·	·	✓
SD	Sleep disorder	·	·	✓
SD	Upper-airway cough syndrome	·	·	✓
SD	Urinary tract infection	✓	✓	✓
SD	Vasculitis	·	·	✓
SRO	Dysgeusia	·	·	✓
SRO	Epistaxis	·	·	✓
SRO	Rash	✓	✓	✓
SRO	Rash erythematous	✓	✓	✓
SRO	Rash pruritic	✓	✓	✓
SRO	Upper-airway cough syndrome	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release